<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Lu Mao" />


<title>Analysis of multistate hierarchical outcomes by the restricted mean time in favor of treatment</title>

<script src="data:application/javascript;base64,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"></script>


<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<link rel="stylesheet" href="data:text/css,body%20%7B%0Abackground%2Dcolor%3A%20%23fff%3B%0Amargin%3A%201em%20auto%3B%0Amax%2Dwidth%3A%20700px%3B%0Aoverflow%3A%20visible%3B%0Apadding%2Dleft%3A%202em%3B%0Apadding%2Dright%3A%202em%3B%0Afont%2Dfamily%3A%20%22Open%20Sans%22%2C%20%22Helvetica%20Neue%22%2C%20Helvetica%2C%20Arial%2C%20sans%2Dserif%3B%0Afont%2Dsize%3A%2014px%3B%0Aline%2Dheight%3A%201%2E35%3B%0A%7D%0A%23TOC%20%7B%0Aclear%3A%20both%3B%0Amargin%3A%200%200%2010px%2010px%3B%0Apadding%3A%204px%3B%0Awidth%3A%20400px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Aborder%2Dradius%3A%205px%3B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Afont%2Dsize%3A%2013px%3B%0Aline%2Dheight%3A%201%2E3%3B%0A%7D%0A%23TOC%20%2Etoctitle%20%7B%0Afont%2Dweight%3A%20bold%3B%0Afont%2Dsize%3A%2015px%3B%0Amargin%2Dleft%3A%205px%3B%0A%7D%0A%23TOC%20ul%20%7B%0Apadding%2Dleft%3A%2040px%3B%0Amargin%2Dleft%3A%20%2D1%2E5em%3B%0Amargin%2Dtop%3A%205px%3B%0Amargin%2Dbottom%3A%205px%3B%0A%7D%0A%23TOC%20ul%20ul%20%7B%0Amargin%2Dleft%3A%20%2D2em%3B%0A%7D%0A%23TOC%20li%20%7B%0Aline%2Dheight%3A%2016px%3B%0A%7D%0Atable%20%7B%0Amargin%3A%201em%20auto%3B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dcolor%3A%20%23DDDDDD%3B%0Aborder%2Dstyle%3A%20outset%3B%0Aborder%2Dcollapse%3A%20collapse%3B%0A%7D%0Atable%20th%20%7B%0Aborder%2Dwidth%3A%202px%3B%0Apadding%3A%205px%3B%0Aborder%2Dstyle%3A%20inset%3B%0A%7D%0Atable%20td%20%7B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dstyle%3A%20inset%3B%0Aline%2Dheight%3A%2018px%3B%0Apadding%3A%205px%205px%3B%0A%7D%0Atable%2C%20table%20th%2C%20table%20td%20%7B%0Aborder%2Dleft%2Dstyle%3A%20none%3B%0Aborder%2Dright%2Dstyle%3A%20none%3B%0A%7D%0Atable%20thead%2C%20table%20tr%2Eeven%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Ap%20%7B%0Amargin%3A%200%2E5em%200%3B%0A%7D%0Ablockquote%20%7B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Apadding%3A%200%2E25em%200%2E75em%3B%0A%7D%0Ahr%20%7B%0Aborder%2Dstyle%3A%20solid%3B%0Aborder%3A%20none%3B%0Aborder%2Dtop%3A%201px%20solid%20%23777%3B%0Amargin%3A%2028px%200%3B%0A%7D%0Adl%20%7B%0Amargin%2Dleft%3A%200%3B%0A%7D%0Adl%20dd%20%7B%0Amargin%2Dbottom%3A%2013px%3B%0Amargin%2Dleft%3A%2013px%3B%0A%7D%0Adl%20dt%20%7B%0Afont%2Dweight%3A%20bold%3B%0A%7D%0Aul%20%7B%0Amargin%2Dtop%3A%200%3B%0A%7D%0Aul%20li%20%7B%0Alist%2Dstyle%3A%20circle%20outside%3B%0A%7D%0Aul%20ul%20%7B%0Amargin%2Dbottom%3A%200%3B%0A%7D%0Apre%2C%20code%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0Aborder%2Dradius%3A%203px%3B%0Acolor%3A%20%23333%3B%0Awhite%2Dspace%3A%20pre%2Dwrap%3B%20%0A%7D%0Apre%20%7B%0Aborder%2Dradius%3A%203px%3B%0Amargin%3A%205px%200px%2010px%200px%3B%0Apadding%3A%2010px%3B%0A%7D%0Apre%3Anot%28%5Bclass%5D%29%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Acode%20%7B%0Afont%2Dfamily%3A%20Consolas%2C%20Monaco%2C%20%27Courier%20New%27%2C%20monospace%3B%0Afont%2Dsize%3A%2085%25%3B%0A%7D%0Ap%20%3E%20code%2C%20li%20%3E%20code%20%7B%0Apadding%3A%202px%200px%3B%0A%7D%0Adiv%2Efigure%20%7B%0Atext%2Dalign%3A%20center%3B%0A%7D%0Aimg%20%7B%0Abackground%2Dcolor%3A%20%23FFFFFF%3B%0Apadding%3A%202px%3B%0Aborder%3A%201px%20solid%20%23DDDDDD%3B%0Aborder%2Dradius%3A%203px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Amargin%3A%200%205px%3B%0A%7D%0Ah1%20%7B%0Amargin%2Dtop%3A%200%3B%0Afont%2Dsize%3A%2035px%3B%0Aline%2Dheight%3A%2040px%3B%0A%7D%0Ah2%20%7B%0Aborder%2Dbottom%3A%204px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Apadding%2Dbottom%3A%202px%3B%0Afont%2Dsize%3A%20145%25%3B%0A%7D%0Ah3%20%7B%0Aborder%2Dbottom%3A%202px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Afont%2Dsize%3A%20120%25%3B%0A%7D%0Ah4%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23f7f7f7%3B%0Amargin%2Dleft%3A%208px%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Ah5%2C%20h6%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23ccc%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Aa%20%7B%0Acolor%3A%20%230033dd%3B%0Atext%2Ddecoration%3A%20none%3B%0A%7D%0Aa%3Ahover%20%7B%0Acolor%3A%20%236666ff%3B%20%7D%0Aa%3Avisited%20%7B%0Acolor%3A%20%23800080%3B%20%7D%0Aa%3Avisited%3Ahover%20%7B%0Acolor%3A%20%23BB00BB%3B%20%7D%0Aa%5Bhref%5E%3D%22http%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0Aa%5Bhref%5E%3D%22https%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0A%0Acode%20%3E%20span%2Ekw%20%7B%20color%3A%20%23555%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Edt%20%7B%20color%3A%20%23902000%3B%20%7D%20%0Acode%20%3E%20span%2Edv%20%7B%20color%3A%20%2340a070%3B%20%7D%20%0Acode%20%3E%20span%2Ebn%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Efl%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Ech%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Est%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Eco%20%7B%20color%3A%20%23888888%3B%20font%2Dstyle%3A%20italic%3B%20%7D%20%0Acode%20%3E%20span%2Eot%20%7B%20color%3A%20%23007020%3B%20%7D%20%0Acode%20%3E%20span%2Eal%20%7B%20color%3A%20%23ff0000%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Efu%20%7B%20color%3A%20%23900%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Eer%20%7B%20color%3A%20%23a61717%3B%20background%2Dcolor%3A%20%23e3d2d2%3B%20%7D%20%0A" type="text/css" />




</head>

<body>




<h1 class="title toc-ignore">Analysis of multistate hierarchical outcomes by the restricted mean time in favor of treatment</h1>
<h4 class="author">Lu Mao</h4>



<div id="introduction" class="section level2">
<h2>INTRODUCTION</h2>
<p>This vignette demonstrates the use of the R-package <code>rmt</code> for the restricted-mean-time-in-favor-of-treatment approach to the analysis of multiple prioritized outcomes.</p>
<div id="data-type" class="section level3">
<h3>Data type</h3>
<p>To recap the methodology, we formulate patient experience with multiple events as a multistate process <span class="math inline">\(Y(t)\)</span> taking values in the ordered set <span class="math inline">\(\{0,1,\ldots, K, K+1\}\)</span>, with a larger integer representing a more series condition. For example, <span class="math inline">\(Y(t)=0\)</span> if a cancer patient is in a state of remission, <span class="math inline">\(Y(t)=1\)</span> if the cancer has relapsed, <span class="math inline">\(Y(t)=2\)</span> if it has metastasized, and <span class="math inline">\(Y(t)=3\)</span> if the patient has died. The methodology in <code>rmt</code> is sufficiently general to be applicable to a wide range of settings, as long as the following assumptions are met:</p>
<ol style="list-style-type: decimal">
<li>The outcome process is <strong>progressive</strong> (can transition only from a less serious to a more serious state), i.e., <span class="math inline">\(Y(t)\leq Y(s)\)</span> for <span class="math inline">\(t\leq s\)</span>;</li>
<li>Death is the only absorbing state, i.e., no competing risks to death (hence “cure models” are not allowed).</li>
</ol>
</div>
<div id="effect-size-estimand" class="section level3">
<h3>Effect size estimand</h3>
<p>Let <span class="math inline">\(Y^{(a)}\)</span> denote the outcome process from group <span class="math inline">\(a\)</span> (<span class="math inline">\(a=1\)</span> for the treatment and <span class="math inline">\(a=0\)</span> for the control). The estimand of interest is constructed under a generalized pairwise comparison framework (Buyse, 2010). With <span class="math inline">\(Y^{(1)}\perp Y^{(0)}\)</span>, let <span class="math display">\[\mu(\tau)=E\int_0^\tau I\{Y^{(1)}(t)&lt; Y^{(0)}(t)\}{\rm d}t -
E\int_0^\tau I\{Y^{(1)}(t)&gt; Y^{(0)}(t)\}{\rm d}t,\]</span> for some pre-specified follow-up time <span class="math inline">\(\tau\)</span>. We call <span class="math inline">\(\mu(\tau)\)</span> the <strong>restricted mean time (RMT) in favor of treatment</strong> and interpret it as the <em>average time gained by the treatment in a more favorable condition</em>. It generalizes the familiar restricted mean survival time to account for the intermediate stages in disease progression. In fact, it can be shown that <span class="math inline">\(\mu(\tau)\)</span> reduces to the net restricted mean survival time (Royston &amp; Parmar, 2011) under the two-state life-death model. For details of the methodology, refer to Mao (2021).</p>
<p>The overall effect size can be decomposed into stage-wise components: <span class="math display">\[\mu(\tau)=\sum_{k=1}^{K+1}\mu_k(\tau)\]</span> with <span class="math display">\[\begin{equation}\label{eq:comp}\tag{*}
\mu_k(\tau)=E\int_0^\tau I\{Y^{(1)}(t)&lt;k, Y^{(0)}(t)=k\}{\rm d}t -
E\int_0^\tau I\{Y^{(0)}(t)&lt;k, Y^{(1)}(t)=k\}{\rm d}t.
\end{equation}\]</span> The component <span class="math inline">\(\mu_k(\tau)\)</span> can be interpreted as the average ``pre-state <span class="math inline">\(k\)</span>’’ time gained by the treatment among those who have not transitioned to state <span class="math inline">\((k+1)\)</span> or higher. It is clear that the last component <span class="math inline">\(\mu_{K+1}(t)\)</span> always stands for the usual net restricted mean survival time.</p>
</div>
</div>
<div id="basic-syntax" class="section level2">
<h2>BASIC SYNTAX</h2>
<div id="data-fitting-and-summarization" class="section level3">
<h3>Data fitting and summarization</h3>
<p>The main data-fitting function is <code>rmtfit()</code>. To use the function, the input data must be organized in the “long” format. Specifically, we need an <code>id</code> variable containing the unique patient identifiers, a <code>time</code> variable containing the times of the transitioning events, a <code>status</code> variable labeling the event type (<code>status=k</code> if transitioning to state <span class="math inline">\(k\)</span> and <code>status=0</code> if censored; note that death is represented by <code>status=K+1</code>), and, finally, a <em>binary</em> <code>trt</code> variable containing the subject-level treatment arm indicators. If <code>id</code>, <code>time</code>, <code>status</code>, and <code>trt</code> are all variables in a data frame <code>data</code>, we can then use the formula form of the function:</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a>obj<span class="ot">=</span><span class="fu">rmtfit</span>(<span class="fu">ms</span>(id,time,status)<span class="sc">~</span>trt,data)</span></code></pre></div>
<p>Otherwise, we can feed the vector-valued variables directly into the function:</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" aria-hidden="true" tabindex="-1"></a>obj<span class="ot">=</span><span class="fu">rmtfit</span>(id,time,status,trt,<span class="at">type=</span><span class="st">&quot;multistate&quot;</span>)</span></code></pre></div>
<p>The (default) <code>type</code> option specifies the input as multistate data rather than recurrent event data (<code>type==&quot;recurrent&quot;</code>).</p>
<p>The returned object <code>obj</code> contains basically all the information about the overall and stage-wise RMTs. To extract relevant information for a particular <span class="math inline">\(\tau=\)</span><code>tau</code>, use</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" aria-hidden="true" tabindex="-1"></a><span class="fu">summary</span>(obj,tau)</span></code></pre></div>
</div>
<div id="plot-of-mucdot" class="section level3">
<h3>Plot of <span class="math inline">\(\mu(\cdot)\)</span></h3>
<p>To plot the estimated <span class="math inline">\(\mu(\tau)\)</span> as a function of <span class="math inline">\(\tau\)</span>, use</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" aria-hidden="true" tabindex="-1"></a><span class="fu">plot</span>(obj,<span class="at">conf=</span><span class="cn">TRUE</span>)</span></code></pre></div>
<p>The option <code>conf=T</code> requests the 95% confidence limits to be overlaid. The color and line type of the confidence limits can be controlled by arguments <code>conf.col</code> and <code>conf.lty</code>, respectively. Other graphical parameters can be specified and, if so, will be passed to the underlying generic <code>plot</code> method.</p>
</div>
<div id="bouquet-plot" class="section level3">
<h3>Bouquet plot</h3>
<p>The dynamic profile of treatment effects as follow-up progresses is captured by the bouquet plot, which puts <span class="math inline">\(\tau\)</span> on the vertical axis and plots the stage-wise restricted mean win/loss times, i.e., the first and second terms on the right hand side of <span class="math inline">\((*)\)</span>, as functions of <span class="math inline">\(\tau\)</span> on the two sides. The bouquet plot is useful because it visualizes the component-wise contributions to the overall effect. To plot it, use</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" aria-hidden="true" tabindex="-1"></a><span class="fu">bouquet</span>(obj)</span></code></pre></div>
<p>Other graphical parameters can be specified and, if so, will be passed to the underlying generic <code>plot</code> method.</p>
</div>
</div>
<div id="an-example-with-a-colon-cancer-trial" class="section level2">
<h2>AN EXAMPLE WITH A COLON CANCER TRIAL</h2>
<div id="data-description" class="section level3">
<h3>Data description</h3>
<p>A landmark colon cancer trial on the efficacy of levamisole and fluorouracil was reported by Moertel et al. (1990). The trial recruited 929 patients with stage C disease and randomly assigned them to levamisole treatment alone, levamisole combined with fluorouracil, and the control. We focus on the comparison between the combined treatment and control groups, consisting of 304 and 314 patients, respectively. The endpoints of interest are cancer relapse and death. The death rates in the treatment and control groups are about 40% and 53%, relapse rates about 39% and 56%, and median follow-up times about 5.7 and 5.1 years, respectively.</p>
<p>The dataset <code>colon_lev</code> (a subset of the <code>colon</code> dataset in the <code>survival</code> package) is contained in the <code>rmt</code> package and can be loaded by</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(rmt)</span>
<span id="cb6-2"><a href="#cb6-2" aria-hidden="true" tabindex="-1"></a><span class="fu">head</span>(colon_lev)</span>
<span id="cb6-3"><a href="#cb6-3" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;   id      time status      rx sex age</span></span>
<span id="cb6-4"><a href="#cb6-4" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; 1  1 2.6502396      1 Lev+5FU   1  43</span></span>
<span id="cb6-5"><a href="#cb6-5" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; 2  1 4.1642710      2 Lev+5FU   1  43</span></span>
<span id="cb6-6"><a href="#cb6-6" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; 3  2 8.4517454      0 Lev+5FU   1  63</span></span>
<span id="cb6-7"><a href="#cb6-7" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; 4  3 1.4839151      1 Control   0  71</span></span>
<span id="cb6-8"><a href="#cb6-8" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; 5  3 2.6365503      2 Control   0  71</span></span>
<span id="cb6-9"><a href="#cb6-9" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; 6  4 0.6707734      1 Lev+5FU   0  66</span></span></code></pre></div>
<p>The dataset is already in a format suitable for <code>rmtfit()</code> (<code>status</code>= 1 for relapse and = 2 for death).</p>
</div>
<div id="estimation-and-inference" class="section level3">
<h3>Estimation and inference</h3>
<p>We first fit the data by</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" aria-hidden="true" tabindex="-1"></a>obj<span class="ot">=</span><span class="fu">rmtfit</span>(<span class="fu">ms</span>(id,time,status)<span class="sc">~</span>rx,<span class="at">data=</span>colon_lev)</span>
<span id="cb7-2"><a href="#cb7-2" aria-hidden="true" tabindex="-1"></a><span class="do">## print the event numbers by group</span></span>
<span id="cb7-3"><a href="#cb7-3" aria-hidden="true" tabindex="-1"></a>obj</span>
<span id="cb7-4"><a href="#cb7-4" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Call:</span></span>
<span id="cb7-5"><a href="#cb7-5" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; rmtfit.formula(formula = ms(id, time, status) ~ rx, data = colon_lev)</span></span>
<span id="cb7-6"><a href="#cb7-6" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-7"><a href="#cb7-7" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;           N State 1 Death Med follow-up time</span></span>
<span id="cb7-8"><a href="#cb7-8" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Control 315     177   168           5.081451</span></span>
<span id="cb7-9"><a href="#cb7-9" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Lev+5FU 304     119   123           5.749487</span></span>
<span id="cb7-10"><a href="#cb7-10" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb7-11"><a href="#cb7-11" aria-hidden="true" tabindex="-1"></a><span class="co"># summarize the inference results for tau=7.5 years</span></span>
<span id="cb7-12"><a href="#cb7-12" aria-hidden="true" tabindex="-1"></a><span class="fu">summary</span>(obj,<span class="at">tau=</span><span class="fl">7.5</span>)</span>
<span id="cb7-13"><a href="#cb7-13" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Call:</span></span>
<span id="cb7-14"><a href="#cb7-14" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; rmtfit.formula(formula = ms(id, time, status) ~ rx, data = colon_lev)</span></span>
<span id="cb7-15"><a href="#cb7-15" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-16"><a href="#cb7-16" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Restricted mean winning time by tau = 7.5:</span></span>
<span id="cb7-17"><a href="#cb7-17" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;           State 1 Survival  Overall</span></span>
<span id="cb7-18"><a href="#cb7-18" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Control 0.2659633 1.130967 1.396930</span></span>
<span id="cb7-19"><a href="#cb7-19" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Lev+5FU 0.6120146 1.750924 2.362938</span></span>
<span id="cb7-20"><a href="#cb7-20" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-21"><a href="#cb7-21" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Restricted mean time in favor of group &quot;Lev+5FU&quot; by time tau = 7.5:</span></span>
<span id="cb7-22"><a href="#cb7-22" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;          Estimate  Std.Err Z value  Pr(&gt;|z|)    </span></span>
<span id="cb7-23"><a href="#cb7-23" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; State 1  0.346051 0.072066  4.8018 1.572e-06 ***</span></span>
<span id="cb7-24"><a href="#cb7-24" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Survival 0.619957 0.213610  2.9023  0.003704 ** </span></span>
<span id="cb7-25"><a href="#cb7-25" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Overall  0.966008 0.252585  3.8245  0.000131 ***</span></span>
<span id="cb7-26"><a href="#cb7-26" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ---</span></span>
<span id="cb7-27"><a href="#cb7-27" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Signif. codes:  0 &#39;***&#39; 0.001 &#39;**&#39; 0.01 &#39;*&#39; 0.05 &#39;.&#39; 0.1 &#39; &#39; 1</span></span></code></pre></div>
<p>From the above output, we conclude that, at 7.5 years, the combined treatment on average gains the patient 0.97 extra year in a more favorable state compared to the control. This total effect size comprises an additional 0.62 year of survival time and 0.35 year of relapse-free time among the survivors. The matrix containing the inferential results can be obtained from <code>summary(obj,tau=7.5)$tab</code>.</p>
</div>
<div id="graphical-analysis" class="section level3">
<h3>Graphical analysis</h3>
<p>Use the following code to construct the bouquet plot and the plot for the estimated <span class="math inline">\(\mu(\cdot)\)</span>:</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" aria-hidden="true" tabindex="-1"></a><span class="co"># set-up plot parameters</span></span>
<span id="cb8-2"><a href="#cb8-2" aria-hidden="true" tabindex="-1"></a>oldpar <span class="ot">&lt;-</span> <span class="fu">par</span>(<span class="at">mfrow =</span> <span class="fu">par</span>(<span class="st">&quot;mfrow&quot;</span>))</span>
<span id="cb8-3"><a href="#cb8-3" aria-hidden="true" tabindex="-1"></a><span class="fu">par</span>(<span class="at">mfrow=</span><span class="fu">c</span>(<span class="dv">1</span>,<span class="dv">2</span>))</span>
<span id="cb8-4"><a href="#cb8-4" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb8-5"><a href="#cb8-5" aria-hidden="true" tabindex="-1"></a><span class="co"># Bouquet plot</span></span>
<span id="cb8-6"><a href="#cb8-6" aria-hidden="true" tabindex="-1"></a><span class="fu">bouquet</span>(obj,<span class="at">main=</span><span class="st">&quot;Bouquet plot&quot;</span>,<span class="at">cex.group=</span><span class="fl">0.8</span>, <span class="at">xlab=</span><span class="st">&quot;Restricted mean win/loss time (years)&quot;</span>,</span>
<span id="cb8-7"><a href="#cb8-7" aria-hidden="true" tabindex="-1"></a>        <span class="at">ylab=</span><span class="st">&quot;Follow-up time (years)&quot;</span>) <span class="co">#cex.group: font size of group labels#</span></span>
<span id="cb8-8"><a href="#cb8-8" aria-hidden="true" tabindex="-1"></a><span class="co"># Plot of RMT in favor of treatment over time</span></span>
<span id="cb8-9"><a href="#cb8-9" aria-hidden="true" tabindex="-1"></a><span class="fu">plot</span>(obj,<span class="at">conf=</span><span class="cn">TRUE</span>,<span class="at">col=</span><span class="st">&#39;red&#39;</span>,<span class="at">conf.col=</span><span class="st">&#39;blue&#39;</span>,<span class="at">conf.lty=</span><span class="dv">2</span>, <span class="at">xlab=</span><span class="st">&quot;Follow-up time (years)&quot;</span>,</span>
<span id="cb8-10"><a href="#cb8-10" aria-hidden="true" tabindex="-1"></a>        <span class="at">ylab=</span><span class="st">&quot;RMT in favor of treatment (years)&quot;</span>,<span class="at">main=</span><span class="st">&quot;Overall&quot;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" /></p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb9-1"><a href="#cb9-1" aria-hidden="true" tabindex="-1"></a><span class="fu">par</span>(oldpar)</span></code></pre></div>
<p>From the left panel, both the restricted mean survival (dark gray) and pre-relapse times (light gray) are clearly in favor of the treatment, both increasingly so as follow-up continues. From the right panel, judging from the lower 95% confidence limit, the treatment effect becomes significant at the 0.05 level soon after randomization and stays so till the end of the study. To plot the component-specific curves , run</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" aria-hidden="true" tabindex="-1"></a><span class="co"># set-up plot parameters</span></span>
<span id="cb10-2"><a href="#cb10-2" aria-hidden="true" tabindex="-1"></a>oldpar <span class="ot">&lt;-</span> <span class="fu">par</span>(<span class="at">mfrow =</span> <span class="fu">par</span>(<span class="st">&quot;mfrow&quot;</span>))</span>
<span id="cb10-3"><a href="#cb10-3" aria-hidden="true" tabindex="-1"></a><span class="fu">par</span>(<span class="at">mfrow=</span><span class="fu">c</span>(<span class="dv">1</span>,<span class="dv">2</span>))</span>
<span id="cb10-4"><a href="#cb10-4" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb10-5"><a href="#cb10-5" aria-hidden="true" tabindex="-1"></a><span class="co"># Plot of component-wise RMT in favor of treatment over time</span></span>
<span id="cb10-6"><a href="#cb10-6" aria-hidden="true" tabindex="-1"></a><span class="fu">plot</span>(obj,<span class="at">k=</span><span class="dv">2</span>,<span class="at">conf=</span><span class="cn">TRUE</span>,<span class="at">col=</span><span class="st">&#39;red&#39;</span>,<span class="at">conf.col=</span><span class="st">&#39;blue&#39;</span>,<span class="at">conf.lty=</span><span class="dv">2</span>, <span class="at">xlab=</span><span class="st">&quot;Follow-up time (years)&quot;</span>,</span>
<span id="cb10-7"><a href="#cb10-7" aria-hidden="true" tabindex="-1"></a>        <span class="at">ylab=</span><span class="st">&quot;RMT in favor of treatment (years)&quot;</span>,<span class="at">main=</span><span class="st">&quot;Survival&quot;</span>)</span>
<span id="cb10-8"><a href="#cb10-8" aria-hidden="true" tabindex="-1"></a><span class="fu">plot</span>(obj,<span class="at">k=</span><span class="dv">1</span>,<span class="at">conf=</span><span class="cn">TRUE</span>,<span class="at">col=</span><span class="st">&#39;red&#39;</span>,<span class="at">conf.col=</span><span class="st">&#39;blue&#39;</span>,<span class="at">conf.lty=</span><span class="dv">2</span>, <span class="at">xlab=</span><span class="st">&quot;Follow-up time (years)&quot;</span>,</span>
<span id="cb10-9"><a href="#cb10-9" aria-hidden="true" tabindex="-1"></a>        <span class="at">ylab=</span><span class="st">&quot;RMT in favor of treatment (years)&quot;</span>,<span class="at">main=</span><span class="st">&quot;Pre-relapse&quot;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" style="display: block; margin: auto;" /></p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb11-1"><a href="#cb11-1" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb11-2"><a href="#cb11-2" aria-hidden="true" tabindex="-1"></a><span class="fu">par</span>(oldpar)</span></code></pre></div>
</div>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<ul>
<li>Buyse, M. (2010). Generalized pairwise comparisons of prioritized outcomes in the two‐sample problem. <em>Statistics in Medicine</em>, 29, 3245–3257.</li>
<li>Mao, L. (2021). On restricted mean time in favour of treatment. <em>Submitted</em>.</li>
<li>Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., … &amp; Veeder, M. H. (1990). Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. <em>New England Journal of Medicine</em>, 322, 352–358.</li>
<li>Royston, P. &amp; Parmar, M. K. (2011). The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. <em>Statistics in Medicine</em>, 30, 2409–2421.</li>
</ul>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
